Advertisement

Supply Chain

The Hackett Group, a Miami–based consulting firm, recently released a report that identifies five strategies to ensure more cost-effective and efficient procurement, reported Supply Chain Quarterly.

Advertisement

The Food and Drug Administration Tuesday issued a final rule that updates the definition of a custom device to include new statutory requirements and procedures.

While Mylan agreed to settle its Medicaid rebate case with the federal government last week for $465 million, the drugmaker is not required to classify EpiPens as a branded drug under Medicaid's rebate program until April 2017, reports CNBC.

Advertisement